LeMaitre Vascular (NASDAQ:LMAT) Stock Price Down 3.5% - Should You Sell?

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) were down 3.5% during mid-day trading on Thursday . The company traded as low as $81.19 and last traded at $81.56. Approximately 58,778 shares traded hands during trading, a decline of 65% from the average daily volume of 169,966 shares. The stock had previously closed at $84.54.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on LMAT shares. Barrington Research lowered shares of LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Lake Street Capital raised their target price on LeMaitre Vascular from $105.00 to $110.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Finally, Oppenheimer downgraded LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $97.83.

LeMaitre Vascular Stock Down 2.5%

The company has a debt-to-equity ratio of 0.48, a current ratio of 16.49 and a quick ratio of 13.83. The business has a 50 day simple moving average of $83.82 and a 200 day simple moving average of $89.08. The stock has a market cap of $1.86 billion, a PE ratio of 41.62, a P/E/G ratio of 2.24 and a beta of 0.83.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.02). The business had revenue of $59.87 million for the quarter, compared to analyst estimates of $57.61 million. LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The business's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.44 EPS. On average, equities research analysts forecast that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a $0.20 dividend. The ex-dividend date was Thursday, May 15th. This represents a $0.80 annualized dividend and a yield of 0.97%. LeMaitre Vascular's dividend payout ratio (DPR) is currently 40.40%.

Insiders Place Their Bets

In other news, CEO George W. Lemaitre sold 4,399 shares of LeMaitre Vascular stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $85.10, for a total value of $374,354.90. Following the transaction, the chief executive officer now directly owns 1,827,003 shares in the company, valued at approximately $155,477,955.30. The trade was a 0.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold 100,000 shares of company stock valued at $8,556,857 over the last 90 days. 9.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Invesco Ltd. increased its position in LeMaitre Vascular by 50.5% during the fourth quarter. Invesco Ltd. now owns 174,998 shares of the medical instruments supplier's stock worth $16,124,000 after acquiring an additional 58,720 shares during the period. Compass Planning Associates Inc increased its holdings in shares of LeMaitre Vascular by 91.4% during the 1st quarter. Compass Planning Associates Inc now owns 11,776 shares of the medical instruments supplier's stock worth $988,000 after purchasing an additional 5,623 shares during the period. Teacher Retirement System of Texas raised its position in shares of LeMaitre Vascular by 31.8% during the fourth quarter. Teacher Retirement System of Texas now owns 101,851 shares of the medical instruments supplier's stock valued at $9,385,000 after buying an additional 24,586 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of LeMaitre Vascular by 3.8% in the fourth quarter. Principal Financial Group Inc. now owns 108,617 shares of the medical instruments supplier's stock valued at $10,008,000 after buying an additional 3,942 shares during the period. Finally, Bank of America Corp DE grew its position in LeMaitre Vascular by 32.8% during the fourth quarter. Bank of America Corp DE now owns 61,752 shares of the medical instruments supplier's stock worth $5,690,000 after buying an additional 15,250 shares in the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.